Predictive oncology inc. issues shareholder letter titled, "revolutionizing medicine: ai-driven biomarker and drug discovery for precision health"

Latest developments expand predictive's ai-driven drug discovery platform to include biomarker discovery and drug repurposing

POAI Ratings Summary

POAI Quant Ranking